Trademark Overview
On Friday, July 29, 2022, a trademark application was filed for GRYTTE with the United States Patent and Trademark Office. The USPTO has given the GRYTTE trademark a serial number of 97525748. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, September 9, 2023. This trademark is owned by Suzhou Shali Biotechnology Co., Ltd.. The GRYTTE trademark is filed in the Pharmaceutical Products category with the following description:
Biological preparations for the treatment of cancer; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Diagnostic agents, preparations and substances for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Protein arrays for diagnosing cancer; Stem cells for medical purposes
